WEEKLY e-ALERT  [ BASIC EDITION ]
Pharma China (www.pharmachinaonline.com) is the most influential English media and source of business intelligence covering the Chinese pharmaceutical sector. Pharma China caters for the growing needs of the international pharmaceutical industry for up-to-date and insightful information and intelligence on China’s burgeoning but increasingly complex healthcare marketplace, and is subscribed by most MNC pharma companies, leading CROs, investment banks, consulting firms active in China as well as relevant industry associations and government agencies.

Note: To view full text of free articles, you need to register as a basic member first and then log in. To view premium articles, you need to subscribe to Pharma China as a premium member. For more information or subscription, please contact info@pharmachinaonline.com. If you wish to unsubscribe from this e-Alert, please reply this e-mail with "Remove" in the subject line.
Editor´s Picks
China's Patent Flood Stifles Foreign Filer Freedom(1/17/2019 )  (Premium)
China's Biopharmas Buffeted by Clashing Market Dynamics(1/16/2019 )  (Premium)
The Market
Chinese mAb Market to Grow 13.7% CAGR between 2017 and 2022(1/16/2019 )  (Premium)
SMEI Predicts Four China Healthcare Sector Trends in 2019(1/15/2019 )  (Premium)
Industry News
Boehringer Ingelheim Expands Biopharma Commercial Manufacturing in China(1/17/2019 )  (Premium)
AstraZeneca to Promote Luye Pharma's Cholesterol TCM in Mainland China(1/16/2019 )  (Premium)
Bio-Thera Partners with Cipla to Market Key Cancer Biosimilar(1/16/2019 )  (Premium)
Ironwood Pharma Announces IBS Drug Linzess Approval in China(1/16/2019 )  (Premium)
Bayer Files IND of Loxo¡¯s Novel Anticancer Vitrakvi in China(1/15/2019 )  (Premium)
Celltrion Set to Enter Chinese Pharmaceutical Market(1/15/2019 )  (Premium)
Adagene Announces Collaboration for Discovery of Novel CAR-T with NIH Affiliated Lab(1/15/2019 )  (Premium)
BeiGene Receives U.S. FDA Breakthrough Therapy Designation for Zanubrutinib in Mantle Cell Lymphoma(1/15/2019 )  (free)
94 Listed Chinese MedPharm Companies Release 2018 Performance Guidance(1/14/2019 )  (Premium)
Bayer Launches Hemophilia A Drug Kovaltry in China(1/14/2019 )  (Premium)
Ascletis and Alphamab Reach Agreement over Anti-PD-L1 for HBV(1/14/2019 )  (Premium)
Regulatory News
Shanghai Introduces Point System for Physician Irregularities(1/16/2019 )  (Premium)
A New Scandal Involving Expired Polio Vaccine under Investigation(1/15/2019 )  (Premium)
General Health
The State Council Issues Trial Plan for Nationally-Organized Centralized Drug Purchase and Application(1/17/2019 )  (Premium)
China to Focus Corruption Fighting on Healthcare and Education Sectors(1/17/2019 )  (Premium)
China Pledges to Advance Poverty Alleviation in Healthcare(1/15/2019 )  (free)
Product/R&D News
CMBG¡¯s AlloJoin the First Stem Cell Drug Application Approved in China for Phase II Trials(1/18/2019 )  (Premium)
API/Bulk Drug News
Novo Nordisk Pharmatech A/S signs Asia Pacific distribution agreement with DKSH(1/16/2019 )  (Premium)
© Wicon International Group¡¡Support by: www.heightow.com Home | Site map | Contact Us | Links